Home
E-submission
Sitemap
Contact us
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE & TOPICS
Article Category
Editorial
Review
Original article
Case report
Images of the issue
Letters to the editor
Others
Browse all articles >
TOPICS
IBD
Microbiota
Tumor
Endoscopy
Functional disorder
Infection
Miscellaneous
Browse all articles >
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Hot topic
Funded articles
Search
Author index
EDITORIAL POLICY
Research & publication ethics
Peer review policy
Copyright & license
Others
- Data sharing policy
- Archiving policy
- Preprint policy
- Advertising policy
- CrossMark policy
FOR CONTRIBUTORS
FOR AUTHORS
Instructions to authors
Review flow
Article processing charge
Author’s checklist
Copyright transfer agreement
E-submission
FOR REVIEWERS
Instructions to reviewers
How to become a reviewer?
FOR READERS
Open access
Subscription information
TOC alerts
How to cite this journal?
Permission request
Search
Intest Res Search
CLOSE
Search
Page Path
HOME
Search
IBD
Performing colonoscopy before steroid induction is associated with shorter steroid use in patients with ulcerative colitis
Taku Kobayashi, Eri Udagawa, Lisa Hirose, Toshifumi Hibi
Intest Res.
2023;21(2):205-215.
Published online December 15, 2022
DOI:
https://doi.org/10.5217/ir.2021.00164
Web of Science 1
Full text
PubReader
ePub
PDF
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, Fumihito Hirai, Kenji Watanabe, Katsuyoshi Matsuoka, Masayuki Saruta, Taku Kobayashi, Brian G Feagan, Chantal Tasset, Robin Besuyen, Chohee Yun, Gerald Crans, Jie Zhang, Akira Kondo, Mamoru Watanabe
Intest Res.
2023;21(1):110-125.
Published online March 11, 2022
DOI:
https://doi.org/10.5217/ir.2021.00143
Web of Science 10
Crossref 9
Full text
PubReader
ePub
PDF
Supplementary Material
Inflammatory Bowel Diseases
Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
Taku Kobayashi, Hiroaki Ito, Toshifumi Ashida, Tadashi Yokoyama, Masakazu Nagahori, Tomoki Inaba, Mitsuhiro Shikamura, Takayoshi Yamaguchi, Tetsuharu Hori, Philippe Pinton, Mamoru Watanabe, Toshifumi Hibi
Intest Res.
2021;19(4):448-460.
Published online August 18, 2020
DOI:
https://doi.org/10.5217/ir.2020.00026
Web of Science 8
Crossref 10
Full text
PubReader
ePub
PDF
Supplementary Material
Corrigendum: Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
Keiji Yagisawa, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Takahiko Toyonaga, Miki Miura, Mari Hayashida, Eiko Saito, Masaru Nakano, Hajime Matsubara, Tadakazu Hisamatsu, Toshifumi Hibi
Intest Res.
2020;18(3):343-344.
Published online July 20, 2020
DOI:
https://doi.org/10.5217/ir.2018.00078-c1
Full text
PubReader
ePub
PDF
Inflammatory bowel diseases
Capsule endoscopy in inflammatory bowel disease: when and how
Ida Hilmi, Taku Kobayashi
Intest Res.
2020;18(3):265-274.
Published online July 7, 2020
DOI:
https://doi.org/10.5217/ir.2019.09165
Web of Science 10
Crossref 12
Full text
PubReader
ePub
PDF
Infliximab biosimilar CT-P13 is interchangeable with its originator for patients with inflammatory bowel disease in real world practice
Tomoo Nakagawa, Taku Kobayashi, Kiyohiro Nishikawa, Fumika Yamada, Satoshi Asai, Yukinori Sameshima, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi
Intest Res.
2019;17(4):504-515.
Published online August 23, 2019
DOI:
https://doi.org/10.5217/ir.2019.00030
Web of Science 13
Crossref 14
Full text
PubReader
ePub
PDF
IBD
Individualized treatment based on
CYP3A5
single-nucleotide polymorphisms with tacrolimus in ulcerative colitis
Shinji Okabayashi, Taku Kobayashi, Eiko Saito, Takahiko Toyonaga, Ryo Ozaki, Shintaro Sagami, Masaru Nakano, Junichi Tanaka, Keiji Yagisawa, Satoshi Kuronuma, Osamu Takeuchi, Toshifumi Hibi
Intest Res.
2019;17(2):218-226.
Published online February 7, 2019
DOI:
https://doi.org/10.5217/ir.2018.00117
Web of Science 1
Crossref 2
Full text
PubReader
ePub
PDF
Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
Keiji Yagisawa, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Takahiko Toyonaga, Miki Miura, Mari Hayashida, Eiko Saito, Masaru Nakano, Hajime Matsubara, Tadakazu Hisamatsu, Toshifumi Hibi
Intest Res.
2019;17(1):87-93.
Published online December 14, 2018
DOI:
https://doi.org/10.5217/ir.2018.00078
Web of Science 8
Crossref 8
Full text
PubReader
ePub
PDF
Seven days triple therapy for eradication of
Helicobacter pylori
does not alter the disease activity of patients with inflammatory bowel disease
Shinichiro Shinzaki, Toshimitsu Fujii, Shigeki Bamba, Maiko Ogawa, Taku Kobayashi, Masahide Oshita, Hiroki Tanaka, Keiji Ozeki, Sakuma Takahashi, Hiroki Kitamoto, Kazuhito Kani, Sohachi Nanjo, Takeshi Sugaya, Yuko Sakakibara, Toshihiro Inokuchi, Kazuki Kakimoto, Akihiro Yamada, Hisae Yasuhara, Yoko Yokoyama, Takuya Yoshino, Akira Matsui, Misaki Nakamura, Taku Tomizawa, Ryosuke Sakemi, Noriko Kamata, Toshifumi Hibi
Intest Res.
2018;16(4):609-618.
Published online October 10, 2018
DOI:
https://doi.org/10.5217/ir.2018.00044
Web of Science 12
Crossref 11
Full text
PubReader
ePub
PDF
Supplementary Material
Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
Taku Kobayashi, Tadakazu Hisamatsu, Yasuo Suzuki, Haruhiko Ogata, Akira Andoh, Toshimitsu Araki, Ryota Hokari, Hideki Iijima, Hiroki Ikeuchi, Yoh Ishiguro, Shingo Kato, Reiko Kunisaki, Takayuki Matsumoto, Satoshi Motoya, Masakazu Nagahori, Shiro Nakamura, Hiroshi Nakase, Tomoyuki Tsujikawa, Makoto Sasaki, Kaoru Yokoyama, Naoki Yoshimura, Kenji Watanabe, Miiko Katafuchi, Mamoru Watanabe, Toshifumi Hibi
Intest Res.
2018;16(2):168-177.
Published online April 30, 2018
DOI:
https://doi.org/10.5217/ir.2018.16.2.168
Web of Science 8
Crossref 8
Full text
PubReader
ePub
PDF
Steroid-refractory extensive enteritis complicated by ulcerative colitis successfully treated with adalimumab
Shinji Okabayashi, Taku Kobayashi, Tomohisa Sujino, Ryo Ozaki, Satoko Umeda, Takahiko Toyonaga, Eiko Saito, Masaru Nakano, Maria Carla Tablante, Shojiroh Morinaga, Toshifumi Hibi
Intest Res.
2017;15(4):535-539.
Published online October 23, 2017
DOI:
https://doi.org/10.5217/ir.2017.15.4.535
Web of Science 1
Crossref 1
Full text
PubReader
ePub
PDF
1
Journal Impact Factor 4.9
ABOUT
Aims and scope
About the journal
About the society
Editorial board
Managing team
Best practice
Metrics
Contact us
ARTICLE & TOPICS
Article Category
Editorial
Review
Original article
Case report
Images of the issue
Letters to the editor
Others
Browse all articles >
TOPICS
IBD
Microbiota
Tumor
Endoscopy
Functional disorder
Infection
Miscellaneous
Browse all articles >
BROWSE ARTICLES
Current issue
All issues
Ahead-of print
Most view
Most download
Most cited
Hot topic
Funded articles
Search
Author index
EDITORIAL POLICY
Research & publication ethics
Peer review policy
Copyright & license
Others
- Data sharing policy
- Archiving policy
- Preprint policy
- Advertising policy
- CrossMark policy
AUTHOR INFORMATION
FOR AUTHORS
Instructions to authors
Review flow
Article processing charge
Author’s checklist
Copyright transfer agreement
E-submission
FOR REVIEWERS
Instructions to reviewers
How to become a reviewer?